TREM2 and Alzheimer disease: Recent studies have demonstrated that some functional molecules specifically expressed in microglia, such as trigger receptor expressed in myeloid cells 2 (TREM2), are significantly associated with the risk of AD, which suggests that microglia not merely passively respond to CNS insults but also actively contribute to the development of this disease (4).